Next Article in Journal
Urban Aerosol Particulate Matter Promotes Necrosis and Autophagy via Reactive Oxygen Species-Mediated Cellular Disorders that Are Accompanied by Cell Cycle Arrest in Retinal Pigment Epithelial Cells
Previous Article in Journal
Subchronic N-acetylcysteine Treatment Decreases Brain Kynurenic Acid Levels and Improves Cognitive Performance in Mice
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Functionalization of Betulinic Acid with Polyphenolic Fragments for the Development of New Amphiphilic Antioxidants

by
Joana L. C. Sousa
1,2,*,
Cristiana Gonçalves
1,
Ricardo M. Ferreira
1,
Susana M. Cardoso
1,
Carmen S. R. Freire
2,
Armando J. D. Silvestre
2 and
Artur M. S. Silva
1,*
1
LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
2
Department of Chemistry, CICECO–Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal
*
Authors to whom correspondence should be addressed.
Antioxidants 2021, 10(2), 148; https://doi.org/10.3390/antiox10020148
Submission received: 6 December 2020 / Revised: 11 January 2021 / Accepted: 15 January 2021 / Published: 20 January 2021
(This article belongs to the Section Natural and Synthetic Antioxidants)

Abstract

:
The present work aimed at the valorization of biomass derived compounds by their transformation into new added-value compounds with enhanced antioxidant properties. In this context, betulinic acid (BA) was decorated with polyphenolic fragments, and polyhydroxylated (E)-2-benzylidene-19,28-epoxyoleanane-3,28-diones 4ad were obtained. For that, the synthetic strategy relied on base-promoted aldol condensation reactions of methyl betulonate, which was previously prepared from natural BA, with appropriate benzaldehydes, followed by cleavage of the methyl protecting groups with BBr3. It is noteworthy that the HBr release during the work-up of the cleavage reactions led to the rearrangement of the lupane-type skeleton of the expected betulonic acid derivatives into oleanane-type compounds 4ad. The synthesized compounds 4ad were designed to have specific substitution patterns at C-2 of the triterpene scaffold, allowing the establishment of a structure-activity relationship. The radical scavenging ability of 4ad was evaluated using the 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid radical cation (ABTS•+) scavenging assays. In particular, derivative 4c, bearing a catechol unit, revealed to be the most efficient scavenger against both free radicals DPPH and ABTS•+. Subsequently, we designed two analogues of the hit derivative 4c in order to achieve more potent antioxidant agents: (i) the first analogue carries an additional unsaturation in its lateral chain at C-2 (analogue 5) and (ii) in the second analogue, E-ring was kept in its open form (analogue 6). It was observed that the presence of an extended π-conjugated system at C-2 contributed to an increased scavenging effect, since analogue 5 was more active than 6, α-tocopherol, and 4c in the ABTS•+ assay.

Graphical Abstract

1. Introduction

Betulinic acid (BA, 1) is a lupane-type pentacyclic triterpenoid (Figure 1). It can be isolated from several sources, but the most reported one is the bark of birch trees (Betula spp.). This triterpenic acid displays important biological properties such as anticancer, antiviral, antibacterial, and antimalarial activities, among others [1,2]. Furthermore, BA (1) has become one of the most studied triterpenes, since some of its synthetic derivatives, namely bevirimat (2) and BMS-955176 (3) (Figure 1), proved to be efficient anti-HIV drugs, reaching phase IIb clinical trials [3,4].
All these evidences encouraged medicinal and organic chemists to start looking to BA (1) as an interesting template for further chemical improvement in order to design new biologically active molecules for different applications [5]. Among them, the anticancer activity should be highlighted due to the high number of recent papers and patents referring the potential of synthetic derivatives of BA (1) as antitumor agents [6,7,8]. In particular, in 2017, Gupta et al. found that some synthetic analogues of BA (1) and betulonic acid, bearing benzylidene-type substituents at C-2, revealed a promising cytotoxic profile against various cancer cell lines (IC50 1–2 µM) [9].
Free radicals as well as reactive oxygen (ROS) and nitrogen (RNS) species play an important role in the development of cancer and other diseases [10,11]. Therefore, the search for new antioxidant agents is still a current topic of intense research. Antioxidants can be divided according to their solubility. Liposoluble antioxidants, mainly vitamins A and E, have demonstrated a therapeutic and preventive role in skin care, neurodegenerative diseases, as well as cardiovascular disease and aging [12,13,14]. On the other hand, flavonoids are well-known water-soluble antioxidants [15,16]. Their antiradical activity relies especially on some of their structural features: the 3,4-dihydroxy substitution (catechol unit) in the B-ring, the C2=C3 double bond conjugated with the carbonyl group at C-4, and free hydroxy groups at C-3 and C-5 [15,16,17]. In addition, 2-styrylchromones are another interesting family of synthetic antioxidants, and comparing their scavenging effect with the correspondent flavones, the contribution of the styryl moiety to the molecular stabilization increases the compound’s antiradical activity [18,19,20].
Bringing all this information together and aiming at the valorization of biomass derived compounds, herein, the functionalization of BA (1) with phenolic units was conducted to obtain amphiphilic antioxidants. Thus, polyhydroxylated (E)-2-benzylidene-19,28-epoxyoleanane-3,28-diones 4ad and two 4c analogues—(E,E)-2-[3-(3,4-dihydroxyphenyl)allylidene]-19,28-epoxyoleanane-3,28-dione (5) and methyl (E)-2-(3,4-dihydroxybenzylidene)betulonate (6) (Figure 2)—were synthesized. These compounds were designed to present different structural features such as (i) variations in the number and position of the hydroxy groups (compounds 4ad); (ii) the presence of catechol moieties (compounds 4c, 5, and 6); (iii) an extended π-conjugated system at C-2 (compound 5); and (iv) the E-ring in its open form similar to the pristine BA (1) (compound 6). Then, all these compounds were submitted to a preliminary scavenging activity evaluation against the 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) radical cation (ABTS•+).

2. Materials and Methods

2.1. Chemistry

2.1.1. General Remarks

Melting points were measured with a Büchi Melting Point B-540 apparatus and are uncorrected. NMR spectra were recorded with Bruker Avance 300 (300.13 MHz for 1H and 75.47 MHz for 13C) or Bruker Avance 500 (500.13 MHz for 1H and 125.77 MHz for 13C) spectrometers, in CDCl3, DMSO-d6, and acetone-d6 as solvents. Chemical shifts (δ) are reported in ppm and coupling constants (J) in Hz; the internal standard was tetramethylsilane (TMS). Unequivocal 13C assignments were made with the aid of 2D gHSQC and gHMBC (delays for one-bond and long-range J C/H couplings were optimized for 145 and 7 Hz, respectively) experiments. Positive ESI mass spectra were acquired with an LTQ Orbitrap XL spectrometer. Preparative thin layer chromatography (TLC) was performed with Macherey–Nagel silica gel G/UV254. Column chromatography was performed with Acros Organics silica gel 60 Å (0.060–0.200 mm). All chemicals and solvents were obtained from commercial sources and used as received or dried by standard procedures. BA (1) was purchased from Aktin Chemicals, Inc. (China). For intermediates 9bd, 12, and 14 (Figure S1), 1H and 13C NMR assignments are only presented for the substituent “R”, since these spectra were all recorded in CDCl3 and the methyl betulonate scaffold (C1–C30) is similar to intermediate 9a, where it was completely assigned.

2.1.2. Synthesis of Methyl Betulonate (7)

This compound was prepared according to a procedure previously described in the literature using Me2SO4 as alkylating agent and PCC as oxidant [3]. White solid (882.6 mg, 86% yield). Mp 165-166 °C (Lit. [21] 168 °C). 1H NMR (300.13 MHz, CDCl3): δ 0.92 (s, 3H, H-25), 0.95 and 0.97 (2 s, 6H, H-26,27), 1.02 and 1.07 (2 s, 6H, H-23,24), 1.15–1.75 (m, 17H), 1.69 (s, 3H, H-30), 1.83–1.94 (m, 3H), 2.17–2.28 (m, 2H), 2.34–2.55 (m, 2H), 2.96–3.04 (m, 1H, H-19), 3.67 (s, 3H, 28-OCH3), 4.60–4.61 (m, 1H, H-29), 4.74 (d, J 2.1 Hz, 1H, H-29) ppm. 13C NMR (75.47 MHz, CDCl3): δ 14.6, 15.8 and 16.0 (C-25,26,27), 19.4 (C-30), 19.6 (CH2), 21.1 and 26.6 (C-23,24), 21.4 (CH2), 25.5 (CH2), 29.7 (CH2), 30.6 (CH2), 32.1 (CH2), 33.6 (CH2), 34.2 (CH2), 36.91*, 36.94 (CH2), 38.3 (CH), 39.6 (CH2), 40.6*, 42.4*, 46.9 (C-19), 47.4 (C-4), 49.4 (CH), 49.9 (CH), 51.3 (28-OCH3), 55.0 (C-5), 56.5*, 109.6 (C-29), 150.5 (C-20), 176.6 (C-28), 218.2 (C-3) ppm. *Unprotonated carbons (C-8,10,14,17). HRMS-ESI m/z calcd. for [C31H48O3+H]+: 469.3682, found: 469.3684.

2.1.3. Synthesis of Methyl (E)-2-Benzylidenebetulonate Derivatives 9ad and 14, and Methyl (E,E)-2-[-3-(3,4-Dimethoxyphenyl)allylidene]betulonate (12)

NaH (51.3 mg, 2.14 mmol) was added to a solution of methyl betulonate (7) (200 mg, 0.427 mmol) in dry THF (8 mL). After few minutes, the appropriate aldehyde 8ad, 11, or 13 (0.641 mmol) was added and the reaction mixture was stirred under N2 at room temperature overnight. After this period, it was poured onto ice and H2O, and the pH was adjusted to 1 with diluted HCl. Then, this aqueous solution was extracted twice with DCM and the organic layer was dried over anhydrous Na2SO4. The solvent was evaporated to dryness, and the obtained residue was purified by silica gel column chromatography or preparative thin layer chromatography using DCM (for 9a) and a mixture of Hex/EtOAc [(10:1) for 9b; (5:1) for 9c,d and 12; (3:1) for 14] as eluents.
Methyl (E)-2-Benzylidenebetulonate (9a). White solid (214 mg, 90% yield). Mp 231–232 °C. 1H NMR (300.13 MHz, CDCl3): δ 0.79 (s, 3H, H-25), 0.96 and 1.01 (2 s, 6H, H-26,27), 1.12 and 1.15 (2 s, 6H, H-23,24), 1.72 (s, 3H, H-30), 0.71–1.96 (m, 18H), 2.17–2.31 (m, 3H, H-1 + 2 CH), 2.97–3.09 (m, 2H, H-1 + CH), 3.68 (s, 3H, 28-OCH3), 4.65 (dd, J 1.4 and 2.4 Hz, 1H, H-29), 4.76 (d, J 2.4 Hz, 1H, H-29), 7.29–7.44 (m, 5H, H-2′,3′,4′,5′,6′), 7.48–7.49 (m, 1H, –CH=) ppm. 13C NMR (75.47 MHz, CDCl3): δ 14.6 and 15.4 (C-26,27), 15.8 (C-25), 19.5 (C-30), 20.4 (CH2), 21.7 (CH2), 22.4 and 29.5 (C-23,24), 25.7 (CH2), 29.7 (CH2), 30.7 (CH2), 32.1 (CH2), 33.1 (CH2), 36.5 (C-10), 36.9 (CH2), 38.3 (CH), 40.5*, 42.5*, 44.4 (C-1), 45.2 (C-4), 46.9 (CH), 48.5 (CH), 49.4 (CH), 51.3 (28-OCH3), 52.8 (C-5), 56.6*, 109.5 (C-29), 128.4 (C-4′), 128.5 (C-3′,5′), 130.3 (C-2′,6′), 134.3 (C-2), 136.0 (C-1′), 137.3 (–CH=), 150.8 (C-20), 176.6 (C-28), 208.3 (C-3) ppm. *Unprotonated carbons (C-8,14,17). HRMS-ESI m/z calcd. for [C38H52O3+H]+: 557.3995, found: 557.4001.
Methyl (E)-2-(4-Methoxybenzylidene)betulonate (9b). White solid (215 mg, 86% yield). Mp 133–135 °C. R = (E)-4-methoxybenzilidene: 1H NMR (300.13 MHz, CDCl3): δ 3.85 (s, 3H, 4′-OCH3), 6.95 (d, J 8.8 Hz, 2H, H-3′,5′), 7.41 (d, J 8.8 Hz, 2H, H-2′,6′), 7.46 (br s, 1H, –CH=) ppm. 13C NMR (75.47 MHz, CDCl3): δ 55.3 (4′-OCH3), 114.0 (C-3′,5′), 128.7 (C-1′), 132.2 (C-2′,6′), 137.2 (−CH=), 159.8 (C-4′) ppm. HRMS-ESI m/z calcd. for [C39H54O4+H]+: 587.4100, found: 587.4103.
Methyl (E)-2-(3,4-Dimethoxybenzylidene)betulonate (9c). Light yellow solid (187 mg, 71% yield). Mp 197–198 °C. R = (E)-3,4-dimethoxybenzylidene: 1H NMR (300.13 MHz, CDCl3): δ 3.89 and 3.93 [2 s, 6H, 3′,4′-(OCH3)2], 6.94 (d, J 8.4 Hz, 1H, H-5′), 6.94 (d, J 2.4 Hz, 1H, H-2′), 7.07 (dd, J 2.4 and 8.4 Hz, 1H, H-6′), 7.44 (br s, 1H, –CH=) ppm. 13C NMR (75.47 MHz, CDCl3): δ 55.88 and 55.92 [3′,4′-(OCH3)2], 111.0 (C-5′), 114.3 (C-2′), 123.0 (C-6′), 128.9 (C-1′), 137.3 (−CH=), 148.6 (C-3′), 149.4 (C-4′) ppm. HRMS-ESI m/z calcd. for [C40H56O5+H]+: 617.4206, found: 617.4210.
Methyl (E)-2-(3,4,5-Trimethoxybenzylidene)betulonate (9d). Light yellow solid (199 mg, 72% yield). Mp 183–184 °C. R = (E)-3,4,5-trimethoxybenzylidene: 1H NMR (300.13 MHz, CDCl3): δ 3.86 and 3.89 [2 s, 9H, 3′,4′,5′-(OCH3)3], 6.64 (s, 2H, H-2′,6′), 7.40 (br s, 1H, –CH=) ppm. 13C NMR (75.47 MHz, CDCl3): δ 56.2 and 61.0 [3′,4′,5′-(OCH3)3], 107.7 (C-2′,6′), 131.5 (C-1′), 137.3 (−CH=), 138.5 and 152.9 (C-3′,4′,5′) ppm. HRMS-ESI m/z calcd. for [C41H58O6+H]+: 647.4312, found: 617.4305.
Methyl (E,E)-2-[3-(3,4-Dimethoxyphenyl)allylidene]betulonate (12). Light yellow solid (148 mg, 54% yield). R = (E,E)-3-(3,4-dimethoxyphenyl)allylidene: 1H NMR (300.13 MHz, CDCl3): δ 3.91 (s, 3H, 4″-OCH3), 3.96 (s, 3H, 3″-OCH3), 6.77–6.89 (m, 1H, H-3′), 6.78 (dd, J 11.2 and 26.9 Hz, 1H, H-2′), 6.86 (d, J 8.5 Hz, 1H, H-5″), 6.98 (d, J 1.9 Hz, 1H, H-2″), 7.09 (dd, J 1.9 and 8.5 Hz, 1H, H-6″), 7.23 (d, J 11.2 Hz, 1H, H-1′) ppm. 13C NMR (75.47 MHz, CDCl3): δ 56.0 (4″-OCH3), 56.2 (3″-OCH3), 109.9 (C-2″), 111.2 (C-5″), 120.8 (C-6″), 121.5 (C-2′), 129.9 (C-1″), 137.8 (C-1′), 140.9 (C-3′), 149.1 (C-3″), 150.0 (C-4″) ppm. HRMS-ESI m/z calcd. for [C42H58O5+H]+: 643.4362, found: 643.4376.
Methyl (E)-2-[3,4-Bis(methoxymethoxy)benzylidene]betulonate (14). White solid (179 mg, 62% yield). Mp 99–101 °C. R = (E)-3,4-bis(methoxymethoxy)benzylidene: 1H NMR (500.13 MHz, CDCl3): δ 3.50 (s, 3H, 3′-OCH2OCH3), 3.53 (s, 3H, 4′-OCH2OCH3), 5.21–5.26 (m, 2H, 3′-OCH2OCH3), 5.28 (s, 2H, 4′-OCH2OCH3), 7.08 (dd, J 2.1 and 8.5 Hz, 1H, H-6′), 7.19 (d, J 8.5 Hz, 1H, H-5′), 7.34 (d, J 2.1 Hz, 1H, H-2′), 7.40 (br s, 1H, –CH=) ppm. 13C NMR (125.77 MHz, CDCl3): δ 56.2 and 56.3 (3′,4′-OCH2OCH3), 95.2 (4′-OCH2OCH3), 95.7 (3′-OCH2OCH3), 115.9 (C-5′), 118.8 (C-2′), 125.5 (C-6′), 130.5 (C-1′), 136.9 (−CH=), 146.9 (C-3′), 147.5 (C-4′) ppm. HRMS-ESI m/z calcd. for [C42H60O7+H]+: 677.4417, found: 677.4429.

2.1.4. Synthesis of 19,28-Epoxyoleanane-3,28-dione-Derived Polyhydroxylated Compounds 4ad and 5

A solution of 1 M BBr3 in DCM (1.1 equiv for each protecting group to be cleaved) was slowly added to a cooled solution (ice bath) of methyl (E)-2-benzylidenebetulonate derivatives 9ad or methyl (E,E)-2-[3-(3,4-dimethoxyphenyl)allylidene]betulonate (12) (100 mg, 0.155–0.180 mmol) in dry DCM (4 mL). The reaction mixture was stirred under N2 at room temperature for 1 h. After this period, it was slowly added to H2O and vigorously stirred for 1 h. Then, this aqueous solution was extracted twice with EtOAc, and the organic layer was dried over anhydrous Na2SO4. The solvent was evaporated to dryness, and the obtained residue was purified by preparative thin layer chromatography using a mixture of Hex/EtOAc [(10:1) for 4a and (2:1) for 4b] as eluents, or recrystallized from a mixture of EtOAc/Hex (1:10) for compounds 4c,d and 5.
(E)-2-Benzylidene-19,28-epoxyoleanane-3,28-dione (4a). White solid (50.8 mg, 52% yield). Mp 268–270 °C. 1H NMR (300.13 MHz, CDCl3): δ 0.82 (s, 3H, H-25), 0.92 and 0.95 (2 s, 6H, H-26,27), 0.97 and 1.04 (2 s, 6H, H-29,30), 1.13 and 1.16 (2 s, 6H, H-23,24), 0.61–1.93 (m, 20H), 2.26 (dd, J 1.7 and 16.3 Hz, 1H, H-1), 3.09 (dd, J 1.7 and 16.3 Hz, 1H, H-1), 3.96 (s, 1H, H-19), 7.30–7.45 (m, 5H, H-2′,3′,4′,5′,6′), 7.49–7.51 (m, 1H, –CH=) ppm. 13C NMR (75.47 MHz, CDCl3): δ 13.6 and 15.1 (C-26,27), 16.2 (C-25), 20.2 (CH2), 21.7 (CH2), 22.3 and 28.8 (C-23,24), 24.0 (CH), 25.5 (CH2), 26.6 (CH2), 27.8 (CH2), 29.5 (CH), 31.9 (CH2), 32.3 (CH2), 32.5 (CH2), 33.6*, 36.1 (CH), 36.6*, 40.0*, 40.4*, 44.7 (C-1), 45.2*, 46.1*, 46.7 (CH), 49.2 (CH), 53.0 (CH), 85.9 (C-19), 128.42 (C-3′,5′), 128.45 and 136.0 (C-1′,4′), 130.3 (C-2′,6′), 134.1 (C-2), 137.4 (−CH=), 179.8 (C-28), 208.1 (C-3) ppm. *Unprotonated carbons (C-4,8,10,14,17,20). HRMS-ESI m/z calcd. for [C37H50O3+H]+: 543.3838, found: 543.3838.
(E)-2-(4-Hydroxybenzylidene)-19,28-epoxyoleanane-3,28-dione (4b). White solid (38.1 mg, 40% yield). Mp 191–193 °C. 1H NMR (300.13 MHz, DMSO-d6): δ 0.72 (s, 3H, H-25), 0.87 and 0.92 (2 s, 6H, H-26,27), 0.95 and 0.96 (2 s, 6H, H-29,30), 1.02 and 1.05 (2 s, 6H, H-23,24), 0.65–1.92 (m, 20H), 2.37 (d, J 16.5 Hz, 1H, H-1), 2.95 (d, J 16.5 Hz, 1H, H-1), 4.03 (s, 1H, H-19), 6.83 (d, J 8.7 Hz, 2H, H-3′,5′), 7.30 (br s, 1H, –CH=), 7.39 (d, J 8.7 Hz, 2H, H-2′,6′), 9.95 (s, 1H, 4′-OH) ppm. 13C NMR (75.47 MHz, DMSO-d6): δ 13.4 and 14.6 (C-26,27), 15.9 (C-25), 19.8 (CH2), 20.8*, 21.1 (CH2), 22.1 and 29.3 (C-23,24), 23.3 and 28.5 (C-29,30), 25.1 (CH2), 25.9 (CH2), 27.5 (CH2), 30.9 (CH2), 31.9 (CH2), 32.1 (CH2), 33.2*, 35.8*, 36.0 (CH), 44.1 (C-1), 44.2*, 45.5*, 45.6 (C-18), 48.1 (CH), 51.7 (CH), 59.8*, 85.1 (C-19), 115.6 (C-3′,5′), 126.4 (C-1′), 130.6 (C-2), 132.5 (C-2′,6′), 136.8 (−CH=), 158.3 (C-4′), 179.0 (C-28), 206.2 (C-3) ppm. *Unprotonated carbons (C-4,8,10,14,17,20). HRMS-ESI m/z calcd. for [C37H50O4+H]+: 559.3787, found: 559.3786.
(E)-2-(3,4-Dihydroxybenzylidene)-19,28-epoxyoleanane-3,28-dione (4c). White solid (51.2 mg, 55% yield). Mp 219–221 °C. 1H NMR (500.13 MHz, Acetone-d6): δ 0.84 (s, 3H, H-25), 1.00 and 1.011 (2 s, 6H, H-26,27), 1.014 and 1.05 (2 s, 6H, H-29,30), 1.09 and 1.14 (2 s, 6H, H-23,24), 0.67–2.02 (m, 20H), 2.40 (d, J 16.3 Hz, 1H, H-1), 3.14 (d, J 16.3 Hz, 1H, H-1), 4.03 (s, 1H, H-19), 6.90 (d, J 8.2 Hz, 1H, H-5′), 6.97 (dd, J 2.2 and 8.2 Hz, 1H, H-6′), 7.08 (d, J 2.2 Hz, 1H, H-2′), 7.34 (br s, 1H, –CH=), 8.21 and 8.42 [2 s, 2H, 3′,4′-(OH)2] ppm. 13C NMR (125.77 MHz, Acetone-d6): δ 13.9 and 15.3 (C-26,27), 16.5 (C-25), 20.9 (CH2), 22.4 (CH2), 26.3 (CH2), 27.2 (CH2), 28.6 (CH2), 23.9 and 29.0 (C-29,30), 22.6 and 29.8** (C-23,24), 32.3 (CH2), 33.2 (CH2), 34.2*, 37.1 (C-10), 37.2 (CH), 40.8*, 41.0*, 45.3*, 45.5 (C-1), 46.6*, 47.1 (CH), 49.7 (C-9), 53.3 (C-5), 86.1 (C-19), 116.2 (C-5′), 118.3 (C-2′), 124.5 (C-6′), 129.0 (C-1′), 132.2 (C-2), 137.9 (–CH=), 145.8 (C-3′), 146.8 (C-4′), 179.4 (C-28), 206.8 (C-3) ppm. *Unprotonated carbons (C-4,8,14,17,20). **Overlapped with the solvent residual signal. HRMS-ESI m/z calcd. for [C37H50O5+H]+: 575.3736, found: 575.3743.
(E)-2-(3,4,5-Trihydroxybenzylidene)-19,28-epoxyoleanane-3,28-dione (4d). Dark brown solid (74.9 mg, 82% yield). Mp > 300 °C. 1H NMR (500.13 MHz, Acetone-d6): δ 0.84 (s, 3H, H-25), 0.997 and 1.009 (2 s, 6H, H-26,27), 1.013 and 1.05 (2 s, 6H, H-29,30), 1.08 and 1.13 (2 s, 6H, H-23,24), 0.65–2.02 (m, 20H), 2.36 (d, J 16.4 Hz, 1H, H-1), 3.15 (dd, J 1.7 and 16.4 Hz, 1H, H-1), 4.04 (s, 1H, H-19), 6.66 (s, 2H, H-2′,6′), 7.26 (br s, 1H, –CH=), 7.82 and 8.17 [2 br s, 3H, 3′,4′,5′-(OH)3] ppm. 13C NMR (125.77 MHz, Acetone-d6): δ 13.9 and 15.3 (C-26,27), 16.5 (C-25), 20.9 (CH2), 22.4 (CH2), 26.3 (CH2), 27.2 (CH2), 28.6 (CH2), 23.9 and 29.0 (C-29,30), 22.6 and 29.8** (C-23,24), 32.3 (CH2), 33.2 (CH2), 34.2*, 37.1 (C-10), 37.2 (CH), 40.7*, 41.0*, 45.3*, 45.5 (C-1), 46.6*, 47.1 (CH), 49.8 (C-9), 53.3 (C-5), 86.1 (C-19), 111.0 (C-2′,6′), 128.0 (C-1′), 132.3 (C-2), 138.2 (−CH=), 135.0, 135.1 and 146.3 (C-3′,4′,5′), 179.4 (C-28), 206.8 (C-3) ppm. *Unprotonated carbons (C-4,8,14,17,20). **Overlapped with the residual solvent signal. HRMS-ESI m/z calcd. for [C37H50O6+H]+: 591.3686, found: 591.3874.
(E,E)-2-[3-(3,4-Dihydroxyphenyl)allylidene]-19,28-epoxyoleanane-3,28-dione (5). Orangish brown solid (51.4 mg, 55% yield). Mp > 300 °C. 1H NMR (300.13 MHz, Acetone-d6): δ 0.87 (s, 3H, H-25), 1.00 and 1.01 (2 s, 6H, H-26,27), 1.02 and 1.05 (2 s, 6H, H-29,30), 1.07 and 1.10 (2 s, 6H, H-23,24), 0.61-2.02 (m, 22H), 2.19–2.26 (m, 1H, H-1), 3.11–3.17 (m, 1H, H-1), 4.04 (s, 1H, H-19), 6.83 (d, J 8.2 Hz, 1H, H-5″), 6.86–7.04 (m, 2H, H-2′,3′), 6.97 (dd, J 2.1 and 8.2 Hz, 1H, H-6″), 7.12 (d, J 2.1 Hz, 1H, H-2″), 7.14–7.18 (m, 1H, H-1′), 8.08 and 8.36 [2 s, 2H, 3″,4″-(OH)2] ppm. 13C NMR (75.47 MHz, Acetone-d6): δ 13.9 and 15.4 (C-26,27), 16.5 (C-25), 20.9 (CH2), 22.3 (CH2), 22.7 and 29.6 (C-23,24), 23.9 and 29.0 (C-29,30), 26.3 (CH2), 27.2 (CH2), 28.6 (CH2), 32.3 (CH2), 33.2 (CH2), 33.3 (CH2), 34.2*, 37.2 (C-10), 40.7*, 41.0*, 43.3 (C-1), 45.3*, 46.6*, 47.1, 49.7 (C-9), 53.7 (C-5), 86.1 (C-19), 114.3 (C-2″), 116.2 (C-5″), 121.1 (C-6″), 121.7 and 141.7 (C-2′,3′), 130.1 (C-1″), 132.5 (C-2), 138.1 (C-1′), 146.1 (C-3″), 147.3 (C-4″), 179.5 (C-28), 206.5 (C-3) ppm. *Unprotonated carbons (C-4,8,14,17,20). **Overlapped with the residual solvent signal. HRMS-ESI m/z calcd. for [C39H52O5+H]+: 601.3893, found: 601.3905.

2.1.5. Synthesis of Methyl (E)-2-(3,4-Dihydroxybenzylidene)betulonate (6)

A diluted solution of HCl 20% (5 mL) was added to a solution of methyl (E)-2-[3,4-bis(methoxymethoxy)benzylidene]betulonate (14) (89.7 mg, 0.133 mmol) in THF (2.5 mL). The reaction was stirred under N2 at room temperature for 3 h. After this period, the reaction mixture was poured into ice and water. Then, this aqueous solution was extracted twice with EtOAc, and the organic layer was dried over anhydrous Na2SO4. The solvent was evaporated to dryness, affording the expected methyl (E)-2-(3,4-dihydroxybenzylidene)betulonate (6) as a white solid (64.0 mg, 82% yield). Mp 170–172 °C. 1H NMR (300.13 MHz, CDCl3): δ 0.78 (s, 3H, H-25), 0.96 and 1.02 (2 s, 6H, H-26,27), 1.11 and 1.16 (2 s, 6H, H-23,24), 1.73 (s, 3H, H-30), 0.71–1.96 (m, 18H), 2.18-2.32 (m, 3H, H-1 + 2 CH), 2.98-3.08 (m, 2H, H-1 + CH), 3.68 (s, 3H, 28-OCH3), 4.66 (s, 1H, H-29), 4.77 (s, 1H, H-29), 5.92 and 7.30 [2 br s, 2H, 3′,4′-(OH)2], 6.95 (d, J 8.5 Hz, 1H, H-5′), 7.00 (d, J 8.5 Hz, 1H, H-6′), 7.17 (br s, 1H, H-2′), 7.49 (br s, 1H, –CH=) ppm. 13C NMR (75.47 MHz, CDCl3): δ 14.6 and 15.4 (C-26,27), 15.9 (C-25), 19.5 (C-30), 20.4 (CH2), 21.7 (CH2), 22.3 and 29.6 (C-23,24), 25.7 (CH2), 29.7 (CH2), 30.7 (CH2), 32.1 (CH2), 33.0 (CH2), 36.4 (C-10), 37.0 (CH2), 38.3 (CH), 40.5*, 42.5*, 44.6 (C-1), 45.1 (C-4), 46.9 (CH), 48.5 (CH), 49.4 (CH), 51.4 (28-OCH3), 52.5 (C-5), 56.6*, 109.6 (C-29), 115.2 (C-5′), 118.8 (C-2′), 123.4 (C-6′), 128.5 (C-1′), 131.6 (C-2), 138.9 (−CH=), 143.7 (C-3′), 145.5 (C-4′), 150.7 (C-20), 176.7 (C-28), 210.1 (C-3) ppm. *Unprotonated carbons (C-8,14,17). HRMS-ESI m/z calcd. for [C38H52O5+H]+: 589.3893, found: 589.3906.

2.2. DPPH and ABTS•+ Scavenging Assays

The compounds capacity for scavenging DPPH and ABTS•+ was evaluated following the procedures previously described by Catarino et al. [22,23]. The compounds under study as well as the positive controls, α-tocopherol and quercetin, were dissolved in a mixture of EtOH/H2O 70%. The DPPH and ABTS•+ stock solutions were prepared using EtOH as solvent, and their absorbance was adjusted between 0.721 ± 0.004 and 0.79 ± 0.01 at 517 and 734 nm, respectively. These assays were undertaken at room temperature. In each assay, three independent experiments were performed, using 5–7 concentrations in duplicate, to obtain the IC50 values, which were calculated from the curves of %inhibition vs compound concentration and expressed as mean ± standard error of the mean (SEM).

3. Results and Discussion

3.1. Synthesis of Polyhydroxylated (E)-2-Benzylidene-19,28-epoxyoleanane-3,28-diones 4ad

Polyhydroxylated (E)-2-benzylidene-19,28-epoxyoleanane-3,28-diones 4ad were synthesized in a two-step approach, starting from methyl betulonate (7) and involving base-promoted aldol condensations with different benzaldehydes, followed by cleavage of the methyl protecting groups (Scheme 1).
Firstly, methyl betulonate (7) was prepared in very good global yield (86%) from BA (1) through the esterification of its carboxyl group with dimethyl sulfate (Me2SO4), followed by the oxidation of its 3-hydroxy group with pyridinium chlorochromate (PCC) (Scheme 2).
The following step involved the base-promoted aldol condensation of methyl betulonate (7) with benzaldehydes 8ad using sodium hydride as base (Scheme 3), affording methyl (E)-2-benzylidenebetulonate derivatives 9ad in good to excellent yields (71–90%). The main feature in the 1H NMR spectra of these compounds is the resonance corresponding to the methylidyne proton of their characteristic α,β-unsaturated carbonyl moiety, which appears as a multiplet at δH 7.48–7.49 ppm for 9a or as a broad singlet at δH 7.40–7.46 ppm for 9bd. The appearance of this resonance at the aromatic region of 1H NMR spectra proves that the aldol condensation reactions were successfully performed. In the case of 9bd, additional singlets at δH 3.85–3.93 ppm were observed, which are attributed to the resonances of protons from protecting groups (–OCH3).
Finally, the last step involved the cleavage of the methyl groups of compounds 9ad with boron tribromide (BBr3), giving rise to the polyhydroxylated (E)-2-benzylidene-19,28-epoxyoleanane-3,28-dione derivatives 4ad in fair to very good yields (40–82%) (Scheme 3). Surprisingly, these compounds were obtained instead of the expected betulonic acid-derived compounds 10ad, through the acid-catalyzed rearrangement of their E-ring into an oleanane-type skeleton corresponding to derivatives 4ad (Scheme 4) [24].
This rearrangement takes place during the work-up of the cleavage reactions with water, due to HBr release, and it was confirmed by 1H and 13C NMR spectroscopy. Therefore, the disappearance of the resonances of the vinylic protons H-29 was observed together with the appearance of a singlet at δH 3.96–4.04 ppm corresponding to H-19 in the 1H NMR spectra. In addition, the singlet corresponding to protons H-30 of the vinylic methyl group shifts to lower frequency values, and there is the appearance of another singlet corresponding to H-29 of the formed methyl group. Furthermore, in the 13C NMR spectra, a new resonance corresponding to C-19 of the new C−O single bond appears at δC 85.1–86.1 ppm.
Another important feature of the 1H NMR spectra of compounds 4bd is the presence of singlets at high frequency values (δH 7.82–9.95 ppm) corresponding to the formed hydroxy groups.
The synthesized compounds 4ad differ in the number and position of the hydroxy groups in order to be screened for their antioxidant activity and stablish a structure–activity relationship (SAR).

3.2. Radical Scavenging Activity of Polyhydroxylated (E)-2-Benzylidene-19,28-epoxyoleanane-3,28-diones 4ad

The radical scavenging ability of new polyhydroxylated (E)-2-benzylidene-19,28-epoxyoleanane-3,28-diones 4ad was tested against DPPH and ABTS•+. Note that DPPH and ABTS•+ assays are widely used as a preliminary assessment of the antioxidant ability of natural or synthetic molecules, and particularly for amphiphilic compounds such as 4ad, since these radicals can be solubilized in both aqueous and organic media. α-Tocopherol was chosen as positive control, since the synthesized (E)-2-benzylidene-19,28-epoxyoleanane-3,28-diones 4ad also possess a hydrophobic moiety. Furthermore, some of the synthesized compounds 4ad present polyphenolic units, so we chose quercetin as positive control too, based on its dietary relevance and acknowledged antioxidant capacities, as well as its wide range of health benefits [25].
Results of the scavenging activity of the tested compounds 4ad against DPPH and ABTS•+ are summarized in Table 1. These two free radicals were efficiently scavenged by derivatives 4c and 4d in a concentration-dependent manner with IC50 values varying from 22.1 to 35.1 µM, being 4c the most efficient scavenger against DPPH, reaching an IC50 value of 22.1 ± 0.6 µM, which was even lower than IC50 value found for α-tocopherol (24.0 ± 0.4 µM). On the other hand, derivatives 4a and 4b did not show any scavenging activity against these two free radicals up to the highest concentration tested (800 µM). Overall, our results are consistent with the theory that the 3,4-dihydroxy (catechol-type) substitution plays an important role in what concerns to the scavenging activity of polyphenolic compounds, and thus, of the (E)-2-benzylidene-19,28-epoxyoleanane-3,28-dione polyphenolic derivatives.

3.3. Analogues Synthesis of the Hit Compound 4c and Evaluation of Their Radical Scavenging Activity

Taking into consideration the SAR findings for the synthesized (E)-2-benzylidene-19,28-epoxyoleanane-3,28-diones 4ad, two analogues of the most active compound (derivative 4c) were synthesized in order to achieve a more complete SAR profile (Figure 3).
To begin with, we designed an oleanane-type derivative carrying an extended π-conjugated system at C-2 (Figure 3) to evaluate if this structural feature can contribute to the molecular stabilization and improve the antioxidant activity of this kind of compounds. Thus, using the 3,4-dimethoxycinnamaldehyde (11) in the base-promoted aldol condensation reaction with methyl betulonate (7), the methyl (E,E)-2-[-3-(3,4-dimethoxyphenyl)allylidene]betulonate (12) was obtained in fair yield (54%) (Scheme 5). Then, after cleavage of its methyl groups using BBr3, the (E,E)-2-[3-(3,4-dihydroxyphenyl)allylidene]-19,28-epoxyoleanane-3,28-dione (5) bearing a catechol moiety and an α,β,γ,δ-diunsaturated carbonyl system was also obtained in fair yield (55%).
With the purpose of comparing the ability of (E)-2-benzylidene-19,28-epoxyoleanane-3,28-dione derivative 4c as antioxidant agent with its correspondent esterified form (Figure 3), methyl (E)-2-(3,4-dihydroxybenzylidene)betulonate (6) was synthesized through a similar procedure as the one described above. However, instead of using methyl groups as protecting groups, methoxymethyl (MOM) groups were used, since they can be easily cleavage under milder reaction conditions [26], thus preventing the occurrence of the E-ring rearrangement. Compound 6 was obtained in fair global yield (51%) through base-promoted aldol condensation of methyl betulonate (7) with 3,4-bis(methoxymethoxy)benzaldehyde (13), which had to be previously prepared from 3,4-dihydroxybenzaldehyde, followed by cleavage of the MOM groups using 20% aqueous HCl (Scheme 6).
Regarding the antioxidant capacity of analogues 5 and 6 in comparison with 4c, the desired effect was not observed in the DPPH assay, since 4c was still the most efficient DPPH scavenger (IC50 22.1 ± 0.6 µM) in comparison with 5 (IC50 24.6 ± 0.6 µM) and 6 (IC50 25.1 ± 0.1 µM) (Table 1). Nonetheless, both analogues 5 and 6 were more efficient ABTS•+ scavengers than 4c as shown by the following order of potencies 5 > 6 ≈ α-tocopherol > 4c (Table 1). In particular, analogue 5 was the most efficient ABTS•+ scavenger (IC50 15.9 ± 0.2 µM), proving that the presence of an extended π-system seems to contribute to the improvement of the scavenging effect of 19,28-epoxyoleanane-3,28-dione-type compounds. In fact, this compound was also more efficient than positive control α-tocopherol (IC50 19.2 ± 0.1 µM) in the ABTS•+ assay.

4. Conclusions

To sum up, polyhydroxylated 19,28-epoxyoleanane-3,28-dione-type and methyl betulonate-type compounds were synthesized in fair overall yields (30–59%), starting from natural BA (1), and were screened as antioxidant agents against DPPH and ABTS•+. Compound 5, bearing a catechol moiety and an extended π-conjugated carbonyl system, emerged as lead compound, since it revealed to be the most efficient scavenger for ABTS•+. In fact, it was more active than α-tocopherol used as positive control and the pristine BA (1), which shows its potential to develop a potent amphiphilic antioxidant. Therefore, this study contributed to the valorization of a natural constituent of biomass by-products, since we were able to transform it into new added-value compounds with potential as amphiphilic antioxidants. Their applications can go through the dietary supplementation, food, and skin care industries.

Supplementary Materials

The following are available online at https://www.mdpi.com/2076-3921/10/2/148/s1, Figure S1: Structures and numbering system of intermediates 9ad, 12, and 14. Figures S2–S25: 1H and 13C NMR spectra of all synthesized compounds.

Author Contributions

Conceptualization, J.L.C.S. and A.M.S.S.; methodology, J.L.C.S., C.G., R.M.F. and S.M.C.; investigation and writing—original draft preparation, J.L.C.S.; writing—review and editing, J.L.C.S., S.M.C., A.J.D.S. and A.M.S.S.; supervision, C.S.R.F., A.J.D.S. and A.M.S.S.; project administration, A.J.D.S. and A.M.S.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financed by Portugal 2020 through FEDER in the frame of POCI and in the scope of the projects: MultiBiorefinery (POCI-01-0145-FEDER-016403), CICECO—Aveiro Institute of Materials (UIDB/50011/2020 & UIDP/50011/2020), and LAQV-REQUIMTE (UIDB/50006/2020), co-financed by FCT/MCTES as well as by EpigenGlicON project (POCI-01-0145-FEDER-029767).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

Susana Cardoso acknowledges AgroForWealth project (CENTRO-01-0145-FEDER-000001) for her researcher contract and Joana Sousa also acknowledges MultiBiorefinery project (POCI-01-0145-FEDER-016403) for her post-doctoral grant.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Moghaddam, M.G.; Ahmad, F.B.H.; Samzadeh-Kermani, A. Biological Activity of Betulinic Acid: A Review. Pharmacol. Pharm. 2012, 3, 119–123. [Google Scholar] [CrossRef] [Green Version]
  2. Ríos, J.L.; Máñez, S. New Pharmacological Opportunities for Betulinic Acid. Planta Med. 2018, 84, 8–19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Regueiro-Ren, A.; Liu, Z.; Chen, Y.; Sin, N.; Sit, S.-Y.; Swidorski, J.J.; Chen, J.; Venables, B.L.; Zhu, J.; Nowicka-Sans, B.; et al. Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity. ACS Med. Chem. Lett. 2016, 7, 568–572. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Martin, D.E.; Salzwedel, K.; Allaway, G.P. Bevirimat: A Novel Maturation Inhibitor for the Treatment of HIV-1 Infection. Antiviral Chem. Chemother. 2008, 19, 107–113. [Google Scholar] [CrossRef] [PubMed]
  5. Sousa, J.L.C.; Freire, C.S.R.; Silvestre, A.J.D.; Silva, A.M.S. Recent Developments in the Functionalization of Betulinic Acid and Its Natural Analogues: A Route to New Bioactive Compounds. Molecules 2019, 24, 355. [Google Scholar] [CrossRef]
  6. Ali-Seyed, M.; Jantan, I.; Vijayaraghavan, K.; Bukhari, S.N.A. Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy. Chem. Biol. Drug Des. 2016, 87, 517–536. [Google Scholar] [CrossRef]
  7. Zhang, D.-M.; Xu, H.-G.; Wang, L.; Li, Y.-J.; Sun, P.-H.; Wu, X.-M.; Wang, G.-J.; Chen, W.-M.; Ye, W.-C. Betulinic Acid and its Derivatives as Potential Antitumor Agents. Med. Res. Rev. 2015, 35, 1127–1155. [Google Scholar] [CrossRef]
  8. Csuk, R. Betulinic acid and its derivatives: A patent review (2008–2013). Expert Opin. Ther. Patents 2014, 24, 913–923. [Google Scholar] [CrossRef]
  9. Gupta, N.; Rath, S.K.; Singh, J.; Qayum, A.; Singh, S.; Sangwan, P.L. Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents. Eur. J. Med. Chem. 2017, 135, 517–530. [Google Scholar] [CrossRef]
  10. Sindhi, V.; Gupta, V.; Sharma, K.; Bhatnagar, S.; Kumari, R.; Dhaka, N. Potential applications of antioxidants—A review. J. Pharm. Res. 2013, 7, 828–835. [Google Scholar] [CrossRef]
  11. Pisoschi, A.M.; Pop, A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur. J. Med. Chem. 2015, 97, 55–74. [Google Scholar] [CrossRef] [PubMed]
  12. Chang, K.-H.; Cheng, M.-L.; Chiang, M.-C.; Chen, C.-M. Lipophilic antioxidants in neurodegenerative diseases. Clin. Chim. Acta 2018, 485, 79–87. [Google Scholar] [CrossRef] [PubMed]
  13. Chong-Han, K. Dietary Lipophilic Antioxidants: Implications and Significance in the Aging Process. Crit. Rev. Food Sci. Nutr. 2010, 50, 931–937. [Google Scholar] [CrossRef] [PubMed]
  14. Lagouri, V. Lipophilic Antioxidants. In Lipids and Skin Health; Pappas, A., Ed.; Springer International Publishing: Cham, Switzerland, 2015; pp. 301–310. [Google Scholar]
  15. Pietta, P.-G. Flavonoids as Antioxidants. J. Nat. Prod. 2000, 63, 1035–1042. [Google Scholar] [CrossRef]
  16. Heim, K.E.; Tagliaferro, A.R.; Bobilya, D.J. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 2002, 13, 572–584. [Google Scholar] [CrossRef]
  17. Tripoli, E.; Guardia, M.L.; Giammanco, S.; Majo, D.D.; Giammanco, M. Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review. Food Chem. 2007, 104, 466–479. [Google Scholar] [CrossRef]
  18. Gomes, A.; Fernandes, E.; Silva, A.M.S.; Santos, C.M.M.; Pinto, D.C.G.A.; Cavaleiro, J.A.S.; Lima, J.L.F.C. 2-Styrylchromones: Novel strong scavengers of reactive oxygen and nitrogen species. Bioorg. Med. Chem. 2007, 15, 6027–6036. [Google Scholar] [CrossRef]
  19. Gomes, A.; Neuwirth, O.; Freitas, M.; Couto, D.; Ribeiro, D.; Figueiredo, A.G.P.R.; Silva, A.M.S.; Seixas, R.S.G.R.; Pinto, D.C.G.A.; Tomé, A.C.; et al. Synthesis and antioxidant properties of new chromone derivatives. Bioorg. Med. Chem. 2009, 17, 7218–7226. [Google Scholar] [CrossRef]
  20. Gomes, A.; Freitas, M.; Fernandes, E.; Lima, J.L.F.C. Biological Activities of 2-Styrylchromones. Mini-Rev. Med. Chem. 2010, 10, 1–7. [Google Scholar] [CrossRef]
  21. Komissarova, N.G.; Belenkova, N.G.; Shitikova, O.V.; Spirikhin, L.V.; Yunusov, M.S. Cyclopropanation of betulonic acid and its methyl ester with dichlorocarbene generated under phase transfer catalysis conditions. Russ. Chem. Bull. 2005, 54, 2659–2663. [Google Scholar] [CrossRef]
  22. Catarino, M.D.; Silva, A.M.S.; Saraiva, S.C.; Sobral, A.J.F.N.; Cardoso, S.M. Characterization of phenolic constituents and evaluation of antioxidant properties of leaves and stems of Eriocephalus africanus. Arabian J. Chem. 2018, 11, 62–69. [Google Scholar] [CrossRef] [Green Version]
  23. Catarino, M.D.; Silva, A.M.S.; Cruz, M.T.; Cardoso, S.M. Antioxidant and anti-inflammatory activities of Geranium robertianum L. decoctions. Food Funct. 2017, 8, 3355–3365. [Google Scholar] [CrossRef] [PubMed]
  24. Dehaen, W.; Mashentseva, A.A.; Seitembetov, T.S. Allobetulin and Its Derivatives: Synthesis and Biological Activity. Molecules 2011, 16, 2443–2466. [Google Scholar] [CrossRef]
  25. Boots, A.W.; Haenen, G.R.M.M.; Bast, A. Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585, 325–337. [Google Scholar] [CrossRef] [PubMed]
  26. Ribeiro, D.; Freitas, M.; Tomé, S.M.; Silva, A.M.S.; Porto, G.; Fernandes, E. Modulation of human neutrophils’ oxidative burst by flavonoids. Eur. J. Med. Chem. 2013, 67, 280–292. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structures of BA (1) and the relevant synthetic BA derivatives bevirimat (2) and BMS-955176 (3).
Figure 1. Chemical structures of BA (1) and the relevant synthetic BA derivatives bevirimat (2) and BMS-955176 (3).
Antioxidants 10 00148 g001
Figure 2. Chemical structures of the target compounds.
Figure 2. Chemical structures of the target compounds.
Antioxidants 10 00148 g002
Scheme 1. Retrosynthetic analysis of (E)-2-benzylidene-19,28-epoxyoleanane-3,28-diones 4ad.
Scheme 1. Retrosynthetic analysis of (E)-2-benzylidene-19,28-epoxyoleanane-3,28-diones 4ad.
Antioxidants 10 00148 sch001
Scheme 2. Synthesis of methyl betulonate (7).
Scheme 2. Synthesis of methyl betulonate (7).
Antioxidants 10 00148 sch002
Scheme 3. Synthesis of (E)-2-benzylidene-19,28-epoxyoleanane-3,28-dione-derived polyhydroxylated compounds 4ad.
Scheme 3. Synthesis of (E)-2-benzylidene-19,28-epoxyoleanane-3,28-dione-derived polyhydroxylated compounds 4ad.
Antioxidants 10 00148 sch003
Scheme 4. Rearrangement of betulonic acid-derived intermediates 10ad (not observed) to 19,28-epoxyoleanane-3,28-dione-type compounds 4ad.
Scheme 4. Rearrangement of betulonic acid-derived intermediates 10ad (not observed) to 19,28-epoxyoleanane-3,28-dione-type compounds 4ad.
Antioxidants 10 00148 sch004
Figure 3. Analogue-based design of compounds 5 and 6.
Figure 3. Analogue-based design of compounds 5 and 6.
Antioxidants 10 00148 g003
Scheme 5. Synthesis of (E,E)-2-[3-(3,4-hydroxyphenyl)allylidene]-19,28-epoxyoleanane-3,28-dione (5).
Scheme 5. Synthesis of (E,E)-2-[3-(3,4-hydroxyphenyl)allylidene]-19,28-epoxyoleanane-3,28-dione (5).
Antioxidants 10 00148 sch005
Scheme 6. Synthesis of methyl (E)-2-(3,4-dihydroxybenzylidene)betulonate (6).
Scheme 6. Synthesis of methyl (E)-2-(3,4-dihydroxybenzylidene)betulonate (6).
Antioxidants 10 00148 sch006
Table 1. Scavenging activity of the tested compounds against DPPH and ABTS•+ (IC50, mean ± SEM).
Table 1. Scavenging activity of the tested compounds against DPPH and ABTS•+ (IC50, mean ± SEM).
CompoundRIC50 (µM)
DPPHABTS•+
Precursors
BA (1)NA800 μMNA800 μM
7NA800 μMNA800 μM
Compounds 4ad (Section 3.1)
4aHNA800 μMNA800 μM
4b4-OHNA800 μMNA800 μM
4c3,4-(OH)222.1 ± 0.629.8 ± 0.1
4d3,4,5-(OH)327.5 ± 0.435.1 ± 0.3
Hit 4c analogues (Section 3.3)
524.6 ± 0.615.9 ± 0.2
625.1 ± 0.119.1 ± 0.3
Positive controls
α-Tocopherol24.0 ± 0.419.2 ± 0.1
Quercetin11.4 ± 0.95.4 ± 0.1
NA—No activity was found up to the highest tested concentration (in superscript).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sousa, J.L.C.; Gonçalves, C.; Ferreira, R.M.; Cardoso, S.M.; Freire, C.S.R.; Silvestre, A.J.D.; Silva, A.M.S. Functionalization of Betulinic Acid with Polyphenolic Fragments for the Development of New Amphiphilic Antioxidants. Antioxidants 2021, 10, 148. https://doi.org/10.3390/antiox10020148

AMA Style

Sousa JLC, Gonçalves C, Ferreira RM, Cardoso SM, Freire CSR, Silvestre AJD, Silva AMS. Functionalization of Betulinic Acid with Polyphenolic Fragments for the Development of New Amphiphilic Antioxidants. Antioxidants. 2021; 10(2):148. https://doi.org/10.3390/antiox10020148

Chicago/Turabian Style

Sousa, Joana L. C., Cristiana Gonçalves, Ricardo M. Ferreira, Susana M. Cardoso, Carmen S. R. Freire, Armando J. D. Silvestre, and Artur M. S. Silva. 2021. "Functionalization of Betulinic Acid with Polyphenolic Fragments for the Development of New Amphiphilic Antioxidants" Antioxidants 10, no. 2: 148. https://doi.org/10.3390/antiox10020148

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop